EXHIBIT 23.2
Published on March 16, 2009
Exhibit
23.2
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We
consent to the incorporation by reference in the Registration Statement of
Rexahn Pharmaceuticals, Inc. on Form S-8 (Registration Statement No.
333-129294) of our report dated March 24, 2008 (which report expresses an
unqualified opinion), relating to the financial statements of Rexahn
Pharmaceuticals, Inc. included in this Annual Report on Form 10-K of Rexahn
Pharmaceuticals, Inc. for the year ended December 31, 2008.
/s/ Lazar, Levine &
Felix, LLP
New York,
New York
March 13,
2009